MCM4在结直肠癌中的表达及意义
Expression and Significance of MCM4 in Colorectal Cancer
DOI: 10.12677/acm.2024.1451569, PDF,   
作者: 李 康, 闫 静:锦州医科大学研究生培养基地临沂市人民医院,山东 临沂;张晓明*, 张海峰*:临沂市人民医院普外科中心三病区,山东 临沂
关键词: 结直肠癌MCM4进展生存预后标志物Colorectal Cancer MCM4 Progress Survival Prognostic Marker
摘要: 目的:分析MCM4在结直肠癌细胞中的表达情况,研究MCM4对结直肠癌细胞的作用,进一步探讨MCM4和结直肠癌(CRC)之间的联系。方法:1) 采用免疫组织化学法比较MCM4在不同结肠组织中的表达情况,分析MCM4与结直肠癌患者临床病理之间的关系。2) 生存分析使用Kaplan-Meier方法,logrank检验评估生存差异。采用Cox回归分析确定MCM4对CRC的预测价值。3) 采用qRT-PCR和Western Blot检测MCM4在结直肠癌细胞系HCT 116和Caco2中的表达水平。4) 构建敲低MCM4的表达载体,建立敲低MCM4的表达细胞系。通过CCK-8细胞增殖实验、细胞克隆形成实验检测CRC细胞的增殖能力。结果:1) MCM4在CRC组织和细胞中的表达水平高于正常结直肠组织和细胞。2) MCM4可促进结直肠癌细胞的增殖能力。3) MCM4的高表达与患者的预后不良显著相关。结论:MCM4促进结直肠癌的发生发展,可能是有效的结直肠肿瘤标志物和潜在的治疗靶点。
Abstract: Objective: To analyze the expression of MCM4 in colorectal cancer cells, study the role of MCM4 on colorectal cancer cells, and further explore the association between MCM4 and colorectal cancer (CRC). Methods: 1) Immunohistochemistry was used to compare the expression of MCM4 in different colon tissues and analyze the relationship between MCM4 and clinicopathology in colorectal cancer patients. 2) Survival analysis was performed using the Kaplan-Meier method with logrank test to assess survival differences. Cox regression analysis was used to determine the predictive value of MCM4 for CRC. 3) The expression levels of MCM4 in colorectal cancer cell lines HCT 116 and Caco2 were detected by qRT-PCR and Western Blot. 4) To construct an expression vector that knocks down MCM4 and establish a cell line expressing the knocked-down MCM4. The proliferative ability of CRC cells was detected by CCK-8 cell proliferation assay and cell clone formation assay. Results: 1) MCM4 is expressed at higher levels in CRC tissues and cells than in normal colorectal tissues and cells. 2) MCM4 promotes the proliferative capacity of colorectal cancer cells. 3) High expression of MCM4 was significantly associated with poor prognosis. Conclusions: MCM4 promotes the development of colorectal cancer and may be an effective colorectal tumor marker and a potential therapeutic target.
文章引用:李康, 闫静, 张晓明, 张海峰. MCM4在结直肠癌中的表达及意义[J]. 临床医学进展, 2024, 14(5): 1422-1432. https://doi.org/10.12677/acm.2024.1451569

参考文献

[1] Weng, J., et al. (2022) Exploring Immunotherapy in Colorectal Cancer. Journal of Hematology & Oncology, 15, Article No. 95. [Google Scholar] [CrossRef] [PubMed]
[2] Li, N., et al. (2021) Incidence, Mortality, Survival, Risk Factor and Screening of Colorectal Cancer: A Comparison among China, Europe, and Northern America. Cancer Letters, 522, 255-268. [Google Scholar] [CrossRef] [PubMed]
[3] Sung, H., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[4] Zygulska, A.L. and Pierzchalski, P. (2022) Novel Diagnostic Biomarkers in Colorectal Cancer. International Journal of Molecular Sciences, 23, Article No. 852. [Google Scholar] [CrossRef] [PubMed]
[5] Gini, A., et al. (2020) Impact of Colorectal Cancer Screening on Cancer-Specific Mortality in Europe: A Systematic Review. European Journal of Cancer, 127, 224-235. [Google Scholar] [CrossRef] [PubMed]
[6] Zong, Z., et al. (2016) Musashi2 as a Novel Predictive Biomarker for Liver Metastasis and Poor Prognosis in Colorectal Cancer. Cancer Medicine, 5, 623-630. [Google Scholar] [CrossRef] [PubMed]
[7] Li, C., et al. (2021) Wnt7a Promotes the Occurrence and Development of Colorectal Adenocarcinoma. Frontiers in Oncology, 11, Article 522899. [Google Scholar] [CrossRef] [PubMed]
[8] Wu, H.K., Liu, C., Fan, X.-X., Wang, H. and Zhou, L. (2017). Spalt-Like Transcription Factor 4 as a Potential Diagnostic and Prognostic Marker of Colorectal Cancer. Cancer Biomarkers, 20, 191-198.[CrossRef
[9] Yuan, D., Li, K., Zhu, K., Yan, R. and Dang, C. (2015) Plasma miR-183 Predicts Recurrence and Prognosis in Patients with Colorectal Cancer. Cancer Biology & Therapy, 16, 268-275. [Google Scholar] [CrossRef] [PubMed]
[10] Forsburg, S.L. (2004) Eukaryotic MCM Proteins: Beyond Replication Initiation. Microbiology and Molecular Biology Reviews, 68, 109-131. [Google Scholar] [CrossRef
[11] Yardimci, H. and Walter, J.C. (2014) Prereplication-Complex Formation: A Molecular Double Take? Nature Structural & Molecular Biology, 21, 20-25. [Google Scholar] [CrossRef] [PubMed]
[12] Xu, Y., Xueling, Y., Si, T., et al. (2021) MCM4 in Human Hepatocellular Carcinoma: A Potent Prognostic Factor Associated with Cell Proliferation. BioScience Trends, 15, 100-106. [Google Scholar] [CrossRef] [PubMed]
[13] Pei, L.-P., Zhang, Y.-Z., Li, G.-Y. and Sun, J.-L. (2022) Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma. Frontiers in Genetics, 13, Article 890591. [Google Scholar] [CrossRef] [PubMed]
[14] Liu, X., et al. (2021) The Alterations and Potential Roles of MCMs in Breast Cancer. Journal of Oncology, 2021, Article ID: 7928937. [Google Scholar] [CrossRef] [PubMed]
[15] Guo, F., et al. (2020) Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer. Technology in Cancer Research & Treatment, 19, 1533033820970688. [Google Scholar] [CrossRef] [PubMed]
[16] Sun, J., et al. (2015) The Architecture of a Eukaryotic Replisome. Nature Structural & Molecular Biology, 22, 976-82. [Google Scholar] [CrossRef] [PubMed]
[17] Freeman, A., et al. (1999) Minichromosome Maintenance Proteins as Biological Markers of Dysplasia and Malignancy. Clinical Cancer Research, 5, 2121-2132.
[18] Going, J.J., et al. (2002) Aberrant Expression of Minichromosome Maintenance Proteins 2 and 5, and Ki-67 in Dysplastic Squamous Oesophageal Epithelium and Barrett’s Mucosa. Gut, 50, 373-377. [Google Scholar] [CrossRef] [PubMed]
[19] Ishimi, Y., et al. (2003) Enhanced Expression of Mcm Proteins in Cancer Cells Derived from Uterine Cervix. European Journal of Biochemistry, 270, 1089-1101. [Google Scholar] [CrossRef] [PubMed]
[20] Meng, M.V., et al. (2001) Minichromosome Maintenance Protein 2 Expression in Prostate: Characterization and Association with Outcome after Therapy for Cancer. Clinical Cancer Research, 7, 2712-2718.
[21] Alison, M.R., Hunt, T. and Forbes, S.J. (2002) Minichromosome Maintenance (MCM) Proteins May Be Pre-Cancer Markers. Gut, 50, 290-291. [Google Scholar] [CrossRef] [PubMed]
[22] Kobayashi, G., Hayashi, T., Sentani, K., et al. (2023) MCM4 Expression Is Associated with High-Grade Histology, Tumor Progression and Poor Prognosis in Urothelial Carcinoma. Diagnostic Pathology, 18, Article No. 106. [Google Scholar] [CrossRef] [PubMed]
[23] Katsuya, N., Ishikawa, A., Kido, A., et al. (2023) Minichromosome Maintenance 4 Is Associated with Cancer Stemness and Poor Survival of Patients with Gastric Cancer. Pathobiology, 90, 147-154. [Google Scholar] [CrossRef] [PubMed]